Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,988,617
  • Shares Outstanding, K 279,833
  • Annual Sales, $ 1,190 K
  • Annual Income, $ -444,040 K
  • 60-Month Beta 0.66
  • Price/Sales 2,522.97
  • Price/Cash Flow N/A
  • Price/Book 4.48
Trade IOVA with:

Options Overview Details

View History
  • Implied Volatility 84.18% ( +0.13%)
  • Historical Volatility 75.19%
  • IV Percentile 36%
  • IV Rank 9.58%
  • IV High 293.08% on 01/25/24
  • IV Low 62.06% on 09/20/23
  • Put/Call Vol Ratio 0.18
  • Today's Volume 8,526
  • Volume Avg (30-Day) 11,257
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 201,470
  • Open Int (30-Day) 182,366

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.37
  • Number of Estimates 7
  • High Estimate -0.31
  • Low Estimate -0.44
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +21.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.31 +1.16%
on 05/16/24
14.23 -26.70%
on 05/06/24
-1.49 (-12.50%)
since 04/16/24
3-Month
10.31 +1.16%
on 05/16/24
18.33 -43.10%
on 02/28/24
+1.28 (+13.99%)
since 02/16/24
52-Week
3.21 +224.92%
on 10/19/23
18.33 -43.10%
on 02/28/24
+2.94 (+39.25%)
since 05/16/23

Most Recent Stories

More News
4 Small-Cap Value Stocks That Could Go Parabolic

These four small-cap stocks scan as deeply undervalued right now.

ACHR : 3.81 (-2.06%)
JOBY : 5.02 (-2.33%)
DNA : 0.8390 (-0.01%)
IOVA : 10.43 (-2.34%)
Why Iovance Stock Is Down 18% Today

Investors are misunderstanding when the biopharma company's flagship drug will begin generating meaningful reportable revenue.

IOVA : 10.43 (-2.34%)
Iovance Biotherapeutics: Q1 Earnings Snapshot

Iovance Biotherapeutics: Q1 Earnings Snapshot

IOVA : 10.43 (-2.34%)
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now

The time to jump into a red-hot growth prospect is usually right now...before any more investors identify the opportunity.

RKLB : 4.24 (-2.30%)
CFLT : 31.53 (-1.07%)
IOVA : 10.43 (-2.34%)
Where Will Iovance Biotherapeutics Stock Be in 5 Years?

Is this rising healthcare stock a good buy right now?

IOVA : 10.43 (-2.34%)
3 Millionaire-Maker Biotech Stocks

The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.

IOVA : 10.43 (-2.34%)
RXRX : 9.51 (-5.00%)
VKTX : 69.06 (-11.47%)
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street

Catalysts lie ahead for both of these companies.

IOVA : 10.43 (-2.34%)
NVAX : 14.40 (+11.63%)
Is Iovance Biotherapeutics Stock a Buy Now?

Let's find out if this biotech can keep up its recent momentum.

IOVA : 10.43 (-2.34%)
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

These companies are in the early days of their growth stories.

IOVA : 10.43 (-2.34%)
CRSP : 55.67 (-2.26%)
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street

Find out why investment banks up and down Wall Street have big expectations for these stocks.

LLY : 771.12 (-2.02%)
COMP : 4.35 (-1.36%)
VKTX : 69.06 (-11.47%)
IOVA : 10.43 (-2.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own...

See More

Key Turning Points

3rd Resistance Point 11.21
2nd Resistance Point 11.00
1st Resistance Point 10.72
Last Price 10.43
1st Support Level 10.23
2nd Support Level 10.02
3rd Support Level 9.74

See More

52-Week High 18.33
Fibonacci 61.8% 12.55
Fibonacci 50% 10.77
Last Price 10.43
Fibonacci 38.2% 8.99
52-Week Low 3.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar